Title : A brief review of the genetics and pharmacogenetics of opioid use disorders.

Pub. Date : 2017 Sep

PMID : 29302220






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In pharmacogenetics of opioid addictions, methadone dose may be regulated by variants in cytochrome P450 2B6 (CYP2B6), a methadone-metabolizing enzyme, and by a locus 300 kb 5" to OPRM1. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
2 In pharmacogenetics of opioid addictions, methadone dose may be regulated by variants in cytochrome P450 2B6 (CYP2B6), a methadone-metabolizing enzyme, and by a locus 300 kb 5" to OPRM1. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
3 In pharmacogenetics of opioid addictions, methadone dose may be regulated by variants in cytochrome P450 2B6 (CYP2B6), a methadone-metabolizing enzyme, and by a locus 300 kb 5" to OPRM1. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
4 In pharmacogenetics of opioid addictions, methadone dose may be regulated by variants in cytochrome P450 2B6 (CYP2B6), a methadone-metabolizing enzyme, and by a locus 300 kb 5" to OPRM1. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens